KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 16.73%.

  • Merck's EBITDA Margin rose 166700.0% to 16.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.14%, marking a year-over-year increase of 136100.0%. This contributed to the annual value of 7.39% for FY2024, which is 310700.0% up from last year.
  • As of Q3 2025, Merck's EBITDA Margin stood at 16.73%, which was up 166700.0% from 9.12% recorded in Q2 2025.
  • Merck's 5-year EBITDA Margin high stood at 16.73% for Q3 2025, and its period low was 62.25% during Q2 2023.
  • Moreover, its 5-year median value for EBITDA Margin was 0.26% (2021), whereas its average is 1.65%.
  • In the last 5 years, Merck's EBITDA Margin tumbled by -641100bps in 2023 and then surged by 762800bps in 2024.
  • Over the past 5 years, Merck's EBITDA Margin (Quarter) stood at 0.26% in 2021, then tumbled by -1128bps to 2.66% in 2022, then plummeted by -1430bps to 40.72% in 2023, then skyrocketed by 105bps to 2.19% in 2024, then skyrocketed by 664bps to 16.73% in 2025.
  • Its EBITDA Margin was 16.73% in Q3 2025, compared to 9.12% in Q2 2025 and 16.0% in Q1 2025.